Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under general anaesthetic
• Isotope bone scan

• Treatment Facilities:
• External beam radiotherapy (EBRT)
• Intensity-modulated radiotherapy
• Chemotherapy

• Support Service Facilities:
• Prostate cancer-specific CNSs
• Urology CNS
• Oncology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	208	928
Performance Status recorded	37%	56%
PSA completed	67%	82%
Gleason Score completed	83%	81%
TNM completed	78%	82%
Multiparametric MRI performed	41%	19%
At least 1 treatment modality recorded	95%	97%

	Specialist MDT	National
No. of men with disease status determined	912	39295
Percentage of men diagnosed with metastatic disease	22%	16%

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	100	2581
Percentage of men with low-risk localised disease receiving radical treatment	0%	4%
No. of men diagnosed with locally advanced disease	353	15573
Percentage of men diagnosed with locally advanced disease receiving radical treatment	64%	68%
No. of men with high risk/locally advanced prostate cancer who received radiotherapy	129	6974
Percentage of men having radical radiotherapy for high-risk/locally advanced disease receiving a brachytherapy boost	2%	5%
No. of men diagnosed with N+ M0 (node positive, no metastases)	63	1821
Percentage of men diagnosed with N+ M0 (node positive, no metastases) receiving docetaxel	6%	14%
No. of men diagnosed with M1 (metastases)	205	6085
Percentage of men diagnosed with M1 (metastases) receiving docetaxel	25%	27%

	Diagnosing Trust	National
No. of men diagnosed with intermediate-risk disease	28	3457
Percentage of men diagnosed with intermediate-risk disease receiving a hypofractionated regimen	100%	91%
No. of men diagnosed with high-risk disease	30	6966
Percentage of men diagnosed with high-risk disease receiving a hypofractionated regimen	99%	59%

	Treatment Centre
No. of men who received radical radiotherapy ()	56
Adjusted percentage of men experiencing at least one GI complication (%)	7%